BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Update Vancouver, British
Form 7 Monthly Progress Report July 2023 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report May 2023 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report May 2023 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report March 2023 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report March 2023 Name of Listed Issuer: Trading Symbol: Number of
Indigenous Innovator: Dr. Nadine Caron’s Quest for Equity in Cancer Care and Research Written by
Form 7 Monthly Progress Report February 2023 Name of Listed Issuer: Trading Symbol: Number of
Revolutionizing Cancer Research: Meet Dr. Juliet Daniel, the Trailblazing Black Scientist Making a Difference in
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]